Sfoglia per Rivista JAMA ONCOLOGY
Paclitaxel and Alisertib in recurrent ovarian cancer
2019 Tomao, F.; Benedetti Panici, P.; Tomao, S.
Paclitaxel and pazopanib in ovarian cancer
2018 Tomao, Federica; Benedetti Panici, Pierluigi; Tomao, Silverio
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial
2019 Cremolini, C; Rossini, D; Dell'Aquila, E; Lonardi, S; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Danesi, R; Aprile, G; Tamburini, E; Barone, C; Masi, G; Pantano, F; Pucci, F; Corsi, Dc; Pella, N; Bergamo, F; Rofi, E; Barbara, C; Falcone, A; Santini, D
Self-responsibility for Our Good Health.
2016 Gasparri, Marialuisa; Mueller, Md; Papadia, A.
Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy. three-year follow-up of a randomized phase 3 trial
2019 Ascierto, P. A.; Long, G. V.; Robert, C.; Brady, B.; Dutriaux, C.; Di Giacomo, A. M.; Mortier, L.; Hassel, J. C.; Rutkowski, P.; Mcneil, C.; Kalinka-Warzocha, E.; Savage, K. J.; Hernberg, M. M.; Lebbe, C.; Charles, J.; Mihalcioiu, C.; Chiarion-Sileni, V.; Mauch, C.; Cognetti, F.; Ny, L.; Arance, A.; Svane, I. M.; Schadendorf, D.; Gogas, H.; Saci, A.; Jiang, J.; Rizzo, J.; Atkinson, V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Paclitaxel and Alisertib in recurrent ovarian cancer | 2019 | Tomao, F.; Benedetti Panici, P.; Tomao, S. | |
| Paclitaxel and pazopanib in ovarian cancer | 2018 | Tomao, Federica; Benedetti Panici, Pierluigi; Tomao, Silverio | |
| Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial | 2019 | Cremolini, C; Rossini, D; Dell'Aquila, E; Lonardi, S; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Danesi, R; Aprile, G; Tamburini, E; Barone, C; Masi, G; Pantano, F; Pucci, F; Corsi, Dc; Pella, N; Bergamo, F; Rofi, E; Barbara, C; Falcone, A; Santini, D | |
| Self-responsibility for Our Good Health. | 2016 | Gasparri, Marialuisa; Mueller, Md; Papadia, A. | |
| Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy. three-year follow-up of a randomized phase 3 trial | 2019 | Ascierto, P. A.; Long, G. V.; Robert, C.; Brady, B.; Dutriaux, C.; Di Giacomo, A. M.; Mortier, L.; Hassel, J. C.; Rutkowski, P.; Mcneil, C.; Kalinka-Warzocha, E.; Savage, K. J.; Hernberg, M. M.; Lebbe, C.; Charles, J.; Mihalcioiu, C.; Chiarion-Sileni, V.; Mauch, C.; Cognetti, F.; Ny, L.; Arance, A.; Svane, I. M.; Schadendorf, D.; Gogas, H.; Saci, A.; Jiang, J.; Rizzo, J.; Atkinson, V. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile